Abstract: Provided are organometallic compounds based on platin or palladium and their various uses including as emitters in devices having the structure of Formula I comprising at least four rings as defined herein. Also provided are formulations comprising these compounds. Further provided are organic light emitting devices and related consumer products that utilize these compounds.

Abstract: A compound having a formula of M(LA)p(LB)q(LC)r, where LA has a structure of Formula I, LB is a bidentate ligand; and LC has a structure of Formula II, is provided. In Formula I and Formula II, the compound can be homoleptic or heteroleptic and can include up to three different ligands; K3 and K4 are each independently a direct bond, O, or S; each of moiety A and moiety B represents a monocyclic ring or a polycyclic, fused-ring structure; each of Z1 and Z2 is C or N; and at least one of RA, RB, RC1, RC2, or RC3 comprises a structure of Formula III, In Formula III, L is bivalent organic linker, and Z is Si or Ge. Each RA, RB, RC1, RC2, and RC3 is independently hydrogen or a General Substituent, and each of R1, R2, and R3 is a General Substituent. Formulations, OLEDs, and consumer products including such compounds are also provided.

Abstract: A compound including a tetradentate ligand, LA, is provided. In the compound, LA is coordinated to a metal M selected from Pt, Pd, Cu, Ag, and Au; LA comprises a first moiety and a second moiety that are different form each other and are independently coordinated to the metal M; the first moiety is a heterocyclic carbene, that is coordinated to the metal M through a metal-carbene bond, while the second moiety is a 5-membered heterocycle; and the ligand LA forms at least one M-O or M-S bond. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of Formula I, is provided. In Formula I, rings A, B, and D are independently 5- or 6-membered rings; Z1-Z3 and X1-X5 are independently C or N; each of K1 and K2 are a direct bond, O, and S; Y1 is BR, NR1, O, S, Se, or CRR?; represents a single bond or no bond; when present, L1, L2, L3, and L4 are each independently a direct bond or a linker; each substituent is hydrogen or a general substituent and can be joined together to form a ring. Formulations, OLEDs, and consumer products containing the same are also provided.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided is a compound comprising a first ligand LA of

Abstract: Provided are compounds comprising a structure of the following Formula I: where the structure of Formula I can be coordinated to a metal M. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound comprising a metal M and a first ligand LA having a structure of Formula I, is described. In Formula I, each independently represents a single bond or a double bond; each of X1? to X4? is independently C, N, or NR?; at least one of X1 to X4 is NR?; each RA?, R?, R1, R2, and R3 is independently hydrogen or a general substituent; at least one of RA?, R?, R1, R2, and R3 comprises the metal M; when X1 and X2 are both NR?, the B atom of Formula I forms a maximum of one direct bond to a nitrogen atom, and does not form a direct bond to an oxygen atom; and any two adjacent RA, R?, R1, R2, and R3 can be joined or fused to form a ring. Formulations, OLEDs, and consumer products including the compounds are also described.

Abstract: Provided are organometallic compounds that include a ligand LA of that are useful as emitters in OLEDs. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: The present disclosure provides a method for treating non-alcoholic steatohepatitis and/or non-alcoholic fatty liver disease in a subject in need thereof, the method comprises administering exosome, an exosome pellet, or physiological solution derived from mesenchymal stem cells (MSCs) to the subject.

Abstract: A control method is provided, applied to an electronic device. The electronic device includes a screen and a knob module. The control method includes: receiving a trigger signal to enable the knob module, and displaying an operating interface corresponding to the knob module on the screen according to the trigger signal, where the operating interface includes a plurality of functional regions that is arranged annularly, and the functional regions are configured to display a plurality of function options, where one of the functional regions shows a marked state; switching the functional region corresponding to the marked state according to a first input signal from the knob module; and selecting the functional region corresponding to the marked state according to a second input signal from the knob module.

Abstract: A calibration device which is configured for calibrating a memory is provided. The calibration device includes an input terminal, a first pull-up circuit, and a first comparator. The input terminal is coupled to an external resistor. The first pull-up circuit is coupled to the input terminal, and configured to receive a power supply voltage. The first pull-up circuit includes a plurality of first pull-up units. The first pull-up units are coupled to each other in parallel. The first comparator is coupled to the input terminal. The first comparator is configured to receive a proportion voltage which is corresponding to the power supply voltage, and output a first control signal to the first pull-up units, such that a resistance of each of the first pull-up units is equal to a resistance of the external resistor.

Abstract: A compound comprising a first ligand LA of Formula I or Formula II: wherein A1 and A2 are each independently C or Si; wherein each RA, and RB independently represents mono to the maximum allowable substitution, or no substitution; wherein each X1, X2, and X3 is independently C or N; wherein each R, R1, R2, R3, R4 and RA is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein LA is complexed to a metal M; wherein M is optionally coordinated to one or more other ligands; wherein the ligand LA is optionally linked with the one or more other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand; and wherein any two substituents are optionally j

Abstract: A driving circuit includes a light-emitting element, a first transistor, a second transistor, a third transistor, a fourth transistor, a first capacitor and a regulator circuit. The first transistor, the second transistor and the light-emitting element are coupled in series between a first system voltage terminal and a second system voltage terminal. A first terminal of the first transistor is coupled to the first system voltage terminal. The third transistor is electrically coupled between a gate terminal and a second terminal of the first transistor. The fourth transistor is electrically coupled between the gate terminal of the first transistor and the second system voltage terminal. A first terminal of the first capacitor is electrically coupled to the gate terminal of the first transistor. A regulator circuit is electrically coupled to a second terminal of the first capacitor.

Abstract: The present disclosure relates to systems and methods for image storage. The methods may include obtaining a first image of a subject. The methods may further include obtaining a second image of the subject. The second image may include scan status information of the subject. The scan status information may be associated with a status of the subject when the first image is acquired. And The methods may also include storing the second image correspondingly with the first image.

Abstract: A method of preparing self-adhesive polyester elastomer composite membrane includes the following steps: mix methyl formate or ethyl acetate with thermoplastic polyester elastomer (TPEE) powder or granules; add a modifier, a photo initiator or a thermal initiator; continue mixing to prepare uniformed mixture; after drying uniformed mixture prepare a polyester elastomer membrane through an injection laminating process and apply pressure sensitive adhesive on one side of the polyester elastomer membrane. Prepared membrane poses good bonding characteristics to textile materials and can be used in production of clothing.

Abstract: A display device includes a substrate and pixels. The substrate has an intermediate region and a peripheral region. Each of the pixels includes sub-pixels. Each of the sub-pixels includes a pad group and a light emitting diode (LED) element. The pad group has a first pad and a second pad. The LED element is electrically connected to the first pad and the second pad. The pixels include standard pixels disposed in the intermediate region and peripheral pixels disposed in the peripheral region. The first pads and the second pads of the pad groups of the sub-pixels of each of the standard pixels are arranged in a first direction. The peripheral pixels include a first peripheral pixel. The first pads and the second pads of the pad groups of the sub-pixels of the first peripheral pixel are arranged in a second direction, and the first direction crosses over the second direction.

Abstract: A light source module includes a light guide plate, a light source, a first color conversion film, at least one optical film and an ink coating. The light guide plate has a first light-emitting surface, a second light-emitting surface opposite to the first light-emitting surface, and a light-incident surface connected between the first light-emitting surface and the second light-emitting surface. The light source is disposed beside the light-incident surface. The first color conversion film is disposed beside the first light-emitting surface. The at least one optical film is disposed beside the light guide plate. The ink coating is disposed on a surface edge or an end surface of at least one of the light guide plate, the first color conversion film, and the at least one optical film, and is configured to allow light to pass therethrough. A display device of the invention is further provided.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A display apparatus includes a substrate and pixels disposed on the substrate. Each of the pixels includes sub-pixels. The substrate has an intermediate region and a peripheral region, where the peripheral region is located between an edge of the substrate and the intermediate region. The pixels include standard pixels disposed in the intermediate region and peripheral pixels disposed in the peripheral region. A color displayed by a sub-pixel of a standard pixel and a color displayed by a sub-pixel of a peripheral pixel are the same, and a distance between a second transistor of the sub-pixel of the standard pixel and a pad of the sub-pixel of the standard pixel is not equal to a distance between a second transistor of the sub-pixel of the peripheral pixel and a pad of the sub-pixel of the peripheral pixel.